[Therapeutic neovascularization by nanotechnology-mediated drug delivery system].
Kubo
Mitsuki
M
Egashira
Kensuke
K
D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D036103:Nanotechnology; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D014652:Vascular Diseases / Q000188:drug therapy*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors